• Home
  • About
  • Webcasts
  • ‘Enforcement 40’ for 2020
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Securities-Docket-Leaderboard_9Sec
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2008 / August / 20 / Court Denies Bristol-Myers’ Motion to Dismiss Securities Class Action

Court Denies Bristol-Myers’ Motion to Dismiss Securities Class Action

By Securities Docket on August 20, 2008, 9:04 pm

U.S. District Judge Paul A. Crotty of the Southern District of New York ruled Wednesday that a securities class action lawsuit can proceed against Bristol-Myers Squibb Co. (BMY), denying the company’s motion to dismiss.  The case concerns disclosures Bristol-Myers made regarding its attempts to settle patent litigation with Canadian drug maker Apotex Inc. over popular blood thinner Plavix.

As reported by Dow Jones Newswires, the court found that “plaintiffs have plausibly pleaded that Bristol-Myers’s statements were rendered misleading by the failure to include relevant information about the nature of the settlement negotiations and the terms of the settlement agreement.  That is, plaintiffs have adequately alleged that a reasonable investor would have considered the undisclosed information material in making investment decisions.”

Read the Dow Jones Newswires article

Blog Widget by LinkWithin

Posted in Class Actions | Tagged Dismissals

« Previous Next »

‘Enforcement 40’ for 2020

Ankura 260x250

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2021 Securities Docket.

Powered by WordPress and Hybrid.